Àü±â»ý¸®ÇÐ ¸ÅÇÎ ¹× ÀýÁ¦ ±â±â ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼ : ½Ã¼ú À¯Çüº°, Á¦Ç° ¹üÀ§º°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2033³â)
Electrophysiology Mapping And Ablation Devices Market Size, Share & Trends Analysis Report By Procedure Type, By Product Coverage, By Region, And Segment Forecasts, 2025 - 2033
»óǰÄÚµå
:
1790213
¸®¼Ä¡»ç
:
Grand View Research
¹ßÇàÀÏ
:
2025³â 07¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 120 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
Àü±â»ý¸®ÇÐ ¸ÅÇÎ ¹× ÀýÁ¦ ±â±â ½ÃÀå °³¿ä
Àü±â »ý¸®ÇÐ ¸ÅÇÎ ¹× ÀýÁ¦ ±â±â ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 257¾ï 2,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2033³â¿¡´Â 626¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇϰí, 2025-2033³â 9.23%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º¹ÀâÇÑ ºÎÁ¤¸Æ, ƯÈ÷ ½É¹æ¼¼µ¿ Áø´Ü ¹× Ä¡·á¸¦ À§ÇÑ Àü±â»ý¸®ÇÐÀû ¸ÅÇÎ ¹× ÀýÁ¦ ÀåºñÀÇ Ã¤Åà Ȯ´ë°¡ ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀÔ´Ï´Ù.
º´¿ø°ú ¿Ü·¡ ¸ðµÎ¿¡¼ ÷´Ü ¸®µë °ü¸® µµ±¸¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÁÂ½Ä »ýȰ½À°ü, Èí¿¬, ¾ËÄÚ¿Ã »ç¿ëÀ¸·Î ÀÎÇÑ ÀþÀº ÃþÀÇ ½ÉÀåÁúȯ ºÎ´ãÀÌ Áõ°¡ÇÏ¸é¼ ÀåºñÀÇ È°¿ëÀÌ °¡¼Óȵǰí ÀÖ½À´Ï´Ù. Á¸½¼¾ØµåÁ¸½¼¼ºñ½ºÀÇ 2024³â 2¿ù ±â»ç¿¡ µû¸£¸é, Àü ¼¼°èÀûÀ¸·Î 3,750¸¸ ¸í ÀÌ»óÀÌ ½É¹æ¼¼µ¿À» ¾Î°í ÀÖ½À´Ï´Ù. 40¼¼ ÀÌ»ó ¼ºÀÎ 4¸í Áß 1¸íÀº Æò»ý µ¿¾È ½É¹æ¼¼µ¿ÀÌ ¹ß»ýÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º¹ÀâÇÑ ºÎÁ¤¸Æ, ƯÈ÷ ½É¹æ¼¼µ¿ÀÇ Áø´Ü ¹× Ä¡·á¸¦ À§ÇØ Àü±â»ý¸®ÇÐÀû ¸ÅÇÎ ¹× ÀýÁ¦ ±â±âÀÇ »ç¿ëÀÌ Áõ°¡Çϰí ÀÖ´Â °ÍÀÌ ½ÃÀåÀÇ ÁÖ¿ä ¼ºÀå ÃËÁø¿äÀÎÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÀåÄ¡´Â ºñÁ¤»óÀûÀÎ Àü±â °æ·Î¸¦ Á¤È®ÇÏ°Ô ½Äº°ÇÒ ¼ö ÀÖ¾î Ä¡·á °á°ú¸¦ °³¼±Çϰí Àç¹ß·üÀ» ³·Ãâ ¼ö ÀÖ½À´Ï´Ù. ÀÓ»ó °¡À̵å¶óÀÎÀÌ Áõ»ó¼º ½É¹æ¼¼µ¿ Ä¡·áÀÇ ÃÖÀü¼± Ä¡·á¹ýÀ¸·Î Ä«Å×ÅÍ ÀýÁ¦¼úÀ» °è¼Ó °Á¶ÇÔ¿¡ µû¶ó, Àü ¼¼°èÀûÀ¸·Î ´ë±Ô¸ð ½Ã¼³°ú ½Å»ý EP ÇÁ·Î±×·¥ ¸ðµÎ¿¡¼ Ä«Å×ÅÍ ÀýÁ¦¼úÀ» äÅÃÇÏ´Â Ãß¼¼°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. 2025³â 3¿ù, Abbott´Â À¯·´¿¡¼ Volt ÆÞ½ºÇʵå ÀýÁ¦¼ú(PFA) ½Ã½ºÅÛÀÇ CE ¸¶Å© ½ÂÀÎÀ» ȹµæÇÏ¿© ½É¹æ¼¼µ¿ Ä¡·á¿¡ »ó¾÷ÀûÀ¸·Î »ç¿ëÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº AbbottÀÇ EnSite X ¸ÅÇÎ Ç÷§Æû°ú ÅëÇյǾî ÇϳªÀÇ Ä«Å×ÅÍ·Î ¸ÅÇÎ, ÆäÀÌ½Ì ¹× ÀýÁ¦¼úÀ» ¼öÇàÇÏ¿© ¿öÅ©Ç÷ο츦 ´Ü¼øÈÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.
º´¿ø°ú ¿Ü·¡ Áø·á ȯ°æ ¸ðµÎ¿¡¼ ÃÖ¼Ò Ä§½ÀÀû ½ÉÀå ½Ã¼ú·ÎÀÇ ÀüȯÀº ÷´Ü EP ¸ÅÇÎ ¹× ÀýÁ¦¼ú µµ±¸¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àåºñ´Â ½Ç½Ã°£ À̹ÌÁö¿Í °íÇØ»óµµ µ¥ÀÌÅ͸¦ Á¦°øÇϸç, ¸®µë °ü¸® ¿öÅ©Ç÷ο쿡 ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù. 2025³â 5¿ù, EP EuropaceÀÇ EHRA-HRS-ESC °øµ¿ ÇÕÀÇ´Â AI ±â¹Ý Àü±â»ý¸®ÇÐ ¿¬±¸ÀÇ Ç¥ÁØÈ °³¼±À» Ã˱¸Çß½À´Ï´Ù. EHRAÀÇ AI üũ¸®½ºÆ®¿¡ µû¸£¸é, ÇʼöÀûÀÎ ¹æ¹ýÀ» º¸°íÇÑ ¿¬±¸´Â 55% ÀÌÇÏ, °Ë»ç µî·Ï ¹× ¸ðµ¨ ÈÆ·ÃÀÇ Åõ¸í¼ºÀº 20% ÀÌÇÏ·Î ³ªÅ¸³µ½À´Ï´Ù. ÀÌ ¼º¸í¼´Â ÇâÈÄ AIÀÇ Àû¿ëÀ» º¸´Ù ÀÓ»óÀû ½Å·Ú¼º°ú ÀçÇö¼ºÀ» ³ôÀÌ´Â ¹æÇâÀ¸·Î À̲ô´Â °ÍÀ» ¸ñÇ¥·Î Çϰí ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå ¼¼°èÀÇ Àü±â»ý¸®ÇÐ ¸ÅÇÎ ¹× ÀýÁ¦ ±â±â ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§
½ÃÀå °èÅë Àü¸Á
»óÀ§ ½ÃÀå Àü¸Á
º¸Á¶ ½ÃÀå Àü¸Á
½ÃÀå ¿ªÇÐ
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
¼¼°è Àü±â»ý¸®ÇÐ ¸ÅÇÎ ¹× ÀýÁ¦ ±â±â : ½ÃÀå ºÐ¼® Åø
»ê¾÷ ºÐ¼® - PorterÀÇ Five Forces ºÐ¼®
PESTLE ºÐ¼®
񃬣
ÀÌ¿ë »ç·Ê ºÐ¼®
Á¦4Àå ¼¼°èÀÇ Àü±â»ý¸®ÇÐ ¸ÅÇÎ ¹× ÀýÁ¦ ±â±â ½ÃÀå ºÎ¹® ºÐ¼®, ½Ã¼ú À¯Çüº°, 2021-2033³â
Á¤ÀÇ¿Í ¹üÀ§
½Ã¼ú À¯Çü ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â°ú 2033³â
ºÎ¹® ´ë½Ãº¸µå
¼¼°èÀÇ Àü±â»ý¸®ÇÐ ¸ÅÇÎ ¹× ÀýÁ¦ ±â±â ½ÃÀå, ½Ã¼ú À¯Çüº°, 2021-2033³â
EP ÀýÁ¦ ÀýÂ÷
½ÃÀå ÃßÁ¤¡¤¿¹Ãø 2021-2033³â
ÀûÀÀÁõº°
½É¹æ¼¼µ¿
¹ßÀÛ¼º AF
Áö¼Ó¼º AF
Àå±â Áö¼Ó¼º/¿µ±¸¼º
¿ì½É¹æ Á¶µ¿
Á½ɹæ Á¶µ¿
¹æ½Ç °áÀý ÀçÁøÀÔ ºó¸Æ(AVNRT)
¿ì½É¹æ ºó¸Æ(AT)
ÁÂ½É¹æ ºó¸Æ(AT)
Right Wolff-Parkinson-White (WPW
Left Wolff-Parkinson-White (WPW)
¿ì½É½Ç ºó¸Æ(VT)
ÁÂ½Ç ½É¹æ ºó¸Æ(VT)
Á¦Ç° À¯Çü
½ºÅĵå¾ó·Ð EP Áø´Ü ÀýÂ÷
½ÃÀå ÃßÁ¤¡¤¿¹Ãø 2021-2033³â
Á¦5Àå ¼¼°èÀÇ Àü±â»ý¸®ÇÐ ¸ÅÇÎ ¹× ÀýÁ¦ ±â±â ½ÃÀå ºÎ¹® ºÐ¼®, Á¦Ç° ¹üÀ§º°, 2021-2033³â
Á¤ÀÇ¿Í ¹üÀ§
Á¦Ç° ¹üÀ§ ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â°ú 2033³â
ºÎ¹® ´ë½Ãº¸µå
¼¼°èÀÇ Àü±â»ý¸®ÇÐ ¸ÅÇÎ ¹× ÀýÁ¦ ±â±â ½ÃÀå, Á¦Ç° ¹üÀ§º°, 2021-2033³â
¸ÅÇÎ ¹× ·¦ ½Ã½ºÅÛ
½ÃÀå ÃßÁ¤¡¤¿¹Ãø 2021-2033³â
X¼± ½Ã½ºÅÛ
¸ÅÇÎ ½Ã½ºÅÛ
EP ·¹ÄÚµù ½Ã½ºÅÛ
ICE ½Ã½ºÅÛ
RF ÀýÁ¦ Á¦³×·¹ÀÌÅÍ
ÆÞ½º Çʵå ÀýÁ¦ Á¦³×·¹ÀÌÅÍ
Cryoablation Generators
Áø´Ü¿ë Ä«Å×ÅÍ
½ÃÀå ÃßÁ¤¡¤¿¹Ãø 2021-2033³â
±âÁ¸
÷´Ü
ÃÊÀ½ÆÄ
ÀýÁ¦ Ä«Å×ÅÍ
½ÃÀå ÃßÁ¤¡¤¿¹Ãø 2021-2033³â
±¹¼Ò ÀýÁ¦ Ä«Å×ÅÍ
dz¼± ÀýÁ¦ Ä«Å×ÅÍ
¾×¼¼¼¸® µð¹ÙÀ̽º
½ÃÀå ÃßÁ¤¡¤¿¹Ãø 2021-2033³â
·ÕÀÎÆ®·Îµà¼½Ã½º
°æÁß°Ýħ
³»ºñ°ÔÀÌ¼Ç ¾×¼¼¼¸®
Á¦6Àå Àü±â»ý¸®ÇÐ ¸ÅÇÎ ¹× ÀýÁ¦ ±â±â ½ÃÀå ºÎ¹® ºÐ¼®, Áö¿ªº°, 2021-2033³â
Áö¿ªº° ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â°ú 2034³â
Áö¿ªº° ½ÃÀå ´ë½Ãº¸µå
Áö¿ª ½ÃÀå ½º³À¼ô
Àü±â»ý¸®ÇÐ ¸ÅÇÎ ¹× ÀýÁ¦ ±â±â ½ÃÀå Á¡À¯À²(Áö¿ªº°), 2024³â°ú 2033³â
ºÏ¹Ì
ºÏ¹ÌÀÇ Àü±â»ý¸®ÇÐ ¸ÅÇÎ ¹× ÀýÁ¦ ±â±â ½ÃÀå, 2021-2033³â
¹Ì±¹
ij³ª´Ù
¸ß½ÃÄÚ
À¯·´
À¯·´ÀÇ Àü±â»ý¸®ÇÐ ¸ÅÇÎ ¹× ÀýÁ¦ ±â±â ½ÃÀå, 2021-2033³â
¿µ±¹
µ¶ÀÏ
ÇÁ¶û½º
ÀÌÅ»¸®¾Æ
½ºÆäÀÎ
³ë¸£¿þÀÌ
½º¿þµ§
µ§¸¶Å©
¾Æ½Ã¾ÆÅÂÆò¾ç
ÀϺ»
Áß±¹
Àεµ
È£ÁÖ
Çѱ¹
ű¹
¶óƾ¾Æ¸Þ¸®Ä«
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
³²¾ÆÇÁ¸®Ä«°øÈ±¹
»ç¿ìµð¾Æ¶óºñ¾Æ
¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
Äí¿þÀÌÆ®
Á¦7Àå °æÀï ±¸µµ
ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷ÀÇ ÃÖ±Ù µ¿Çâ°ú ¿µÇ⠺м®
±â¾÷ ºÐ·ù
±â¾÷ °³¿ä
Siemens Healthineers
Koninklijke Philips NV
Abbott
Johnson & Johnson(Biosense Webster)
GE HealthCare
Boston Scientific Corporation
Medtronic
BIoTronik SE & Co KG
MicroPort Scientific Corporation
CardioFocus, Inc.
LSH
¿µ¹® ¸ñÂ÷
Electrophysiology Mapping And Ablation Devices Market Summary
The global electrophysiology mapping and ablation devices market size was estimated at USD 25.72 billion in 2024 and is projected to reach USD 62.61 billion by 2033, growing at a CAGR of 9.23% from 2025 to 2033. Growing adoption of electrophysiology (EP) mapping and ablation devices for the diagnosis and treatment of complex arrhythmias, particularly atrial fibrillation, is a key driver of market growth.
Rising demand for advanced rhythm management tools in both hospital and ambulatory settings, coupled with the increasing burden of cardiac conditions among younger populations due to sedentary lifestyles, smoking, and alcohol use, is accelerating device utilization. According to a February 2024 article by Johnson & Johnson Services, Inc., over 37.5 million people globally are affected by atrial fibrillation. Roughly 1 in 4 adults over 40 are projected to develop the condition during their lifetime. The increasing use of electrophysiology mapping and ablation devices for diagnosing and treating complex arrhythmias, especially atrial fibrillation, is a major growth catalyst for the market. These devices allow for highly precise localization of abnormal electrical pathways, improving procedural outcomes and reducing recurrence rates. As clinical guidelines continue to emphasize catheter ablation as a frontline therapy for symptomatic AF, adoption is gaining momentum among both high-volume centers and emerging EP programs worldwide. In March 2025, Abbott received CE Mark approval in Europe for its Volt Pulsed Field Ablation (PFA) System, enabling commercial use for atrial fibrillation treatment. The system integrates with Abbott's EnSite X mapping platform and is designed to simplify workflows using a single catheter for mapping, pacing, and ablation.
The shift toward minimally invasive cardiac procedures in both hospital and ambulatory care environments is driving demand for advanced EP mapping and ablation tools. These devices are becoming integral to rhythm management workflows, offering real-time imaging and high-resolution data. In May 2025, a joint EHRA-HRS-ESC consensus in EP Europace urged improved standardization in AI-based electrophysiology research. The EHRA AI checklist showed that fewer than 55% of studies reported essential methods, with transparency in trial registration and model training below 20%, highlighting the need for more rigorous reporting practices. The statement aims to guide future AI applications toward greater clinical reliability and reproducibility.
Global Electrophysiology Mapping And Ablation Devices Market Report Segmentation
This report forecasts revenue growth at the global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. for this study, Grand View Research has segmented the global electrophysiology mapping and ablation devices market report based on procedure type, product coverage, and region:
Procedure Type Outlook (Revenue, USD Thousand, 2021 - 2033)
EP Ablation Procedures
By Indication
Atrial Fibrillation
Paroxysmal AF
Persistent AF
Long standing persistent/permanent
Right Atrial Flutter
Left Atrial Flutter
Atrioventricular Nodal Reentry Tachycardia (AVNRT)
Right Atrial Tachycardia (AT)
Left Atrial Tachycardia (AT)
Right Wolff-Parkinson-White (WPW
Left Wolff-Parkinson-White (WPW)
Right Ventricular Tachycardia (VT)
Left Ventricular Tachycardia (VT)
Stand-Alone EP Diagnostic Procedures
By Product Type
Focal Ablation Catheter
Radiofrequency (RF)
Conventional
Irrigated-tip
Contact-Force-Sensing
Standard
Alternative Energy
Pulsed Field Ablation
Balloon Ablation Catheters
Product Coverage Outlook (Revenue, USD Million, 2021 - 2033)
Mapping & Lab Systems
X-Ray Systems
Mapping Systems
EP Recording Systems
ICE Systems
RF Ablation Generators
Pulsed Field Ablation Generators
Cryoablation Generators
Diagnostic Catheters
Conventional
Fixed
Steerable
Advanced
Ultrasound
Ablation Catheters
Focal Ablation Catheter
Radiofrequency (RF)
Conventional
Irrigated-tip
Contact-Force-Sensing
Standard
Alternative Energy
Pulsed Field Ablation
Balloon Ablation Catheters
Accessory Devices
Long Introducer Sheaths
Fixed
Steerable
Transseptal Needles
Navigational Accessories
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
South Korea
Australia
Thailand
Latin America
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment scope
1.1.2. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR's internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Procedure type outlook
2.2.2. Product coverage outlook
2.3. Competitive Insights
Chapter 3. Global Electrophysiology (EP) Mapping and Ablation Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Global Electrophysiology (EP) Mapping and Ablation Devices: Market Analysis Tools
3.3.1. Industry Analysis - Porter's
3.3.2. PESTLE Analysis
3.4. Technology Landscape
3.5. Case Study Analysis
Chapter 4. Global Electrophysiology (EP) Mapping and Ablation Devices Market Segment Analysis, By Procedure Type, 2021 - 2033 (USD Million)
4.1. Definition and Scope
4.2. Procedure Type Market Share Analysis, 2024 & 2033
4.3. Segment Dashboard
4.4. Global Electrophysiology (EP) Mapping and Ablation Devices Market, by Procedure Type, 2021 to 2033
4.5. EP Ablation Procedures
4.5.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.2. By Indication
4.5.3. Atrial Fibrillation
4.5.3.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.3.2. Paroxysmal AF
4.5.3.2.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.3.3. Persistent AF
4.5.3.3.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.3.4. Long standing persistent/permanent
4.5.3.4.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.4. Right Atrial Flutter
4.5.4.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.5. Left Atrial Flutter
4.5.5.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.6. Atrioventricular Nodal Reentry Tachycardia (AVNRT)
4.5.6.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.7. Right Atrial Tachycardia (AT)
4.5.7.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.8. Left Atrial Tachycardia (AT)
4.5.8.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.9. Right Wolff-Parkinson-White (WPW)
4.5.9.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.10. Left Wolff-Parkinson-White (WPW)
4.5.10.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.11. Right Ventricular Tachycardia (VT)
4.5.11.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.12. Left Ventricular Tachycardia (VT)
4.5.12.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.13. By Product Type
4.5.13.1. Focal ablation catheter
4.5.13.1.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.13.1.2. Radiofrequency (RF)
4.5.13.1.2.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.13.1.2.2. Conventional
4.5.13.1.2.2.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.13.1.2.3. Irrigated-tip
4.5.13.1.2.3.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.13.1.2.3.2. Contact-force-sensing
4.5.13.1.3. Alternative energy
4.5.13.1.3.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.13.1.4. Pulsed field ablation
4.5.13.1.4.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.13.2. Balloon ablation catheters
4.5.13.2.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.6. Stand-Alone EP Diagnostic Procedures
4.6.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
Chapter 5. Global Electrophysiology (EP) Mapping and Ablation Devices Market Segment Analysis, By Product Coverage, 2021 - 2033 (USD Million)
5.1. Definition and Scope
5.2. Product Coverage Market Share Analysis, 2024 & 2033
5.3. Segment Dashboard
5.4. Global Electrophysiology (EP) Mapping and Ablation Devices Market, by Product Coverage, 2021 to 2033
5.5. Mapping & Lab Systems
5.5.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.5.2. X-Ray Systems
5.5.2.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.5.3. Mapping Systems
5.5.3.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.5.4. EP Recording Systems
5.5.4.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.5.5. ICE Systems
5.5.5.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.5.6. RF Ablation Generators
5.5.6.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.5.7. Pulsed Field Ablation Generators
5.5.7.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.5.8. Cryoablation Generators
5.5.8.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.6. Diagnostic Catheters
5.6.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.6.2. Conventional
5.6.2.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.6.2.2. Fixed
5.6.2.2.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.6.2.3. Steerable
5.6.2.3.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.6.3. Advanced
5.6.3.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.6.4. Ultrasound
5.6.4.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.7. Ablation Catheters
5.7.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.7.2. Focal Ablation Catheter
5.7.2.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.7.2.2. Radiofrequency (RF)
5.7.2.2.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.7.2.2.2. Conventional
5.7.2.2.2.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.7.2.2.3. Irrigated-tip
5.7.2.2.3.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.7.2.2.3.2. Contact-force-sensing
5.7.2.2.3.2.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.7.2.2.3.3. Standard
5.7.2.2.3.3.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.7.2.3. Alternative energy
5.7.2.3.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.7.2.4. Pulsed field ablation
5.7.2.4.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.7.3. Balloon Ablation Catheters
5.7.3.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.8. Accessory Devices
5.8.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.8.2. Long Introducer Sheaths
5.8.2.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.8.2.2. Fixed
5.8.2.2.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.8.2.3. Steerable
5.8.2.3.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.8.3. Transseptal Needles
5.8.3.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.8.3.2. Conventional
5.8.3.2.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.8.3.3. RF
5.8.3.3.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.8.4. Navigational Accessories
5.8.4.1. Market estimates and forecast 2021 - 2033 (USD Million)
Chapter 6. Electrophysiology (EP) Mapping and Ablation Devices Market Segment Analysis, By Region, 2021 - 2033 (USD Million)
6.1. Regional Market Share Analysis, 2024 & 2034
6.2. Regional Market Dashboard
6.3. Regional Market Snapshot
6.4. Electrophysiology (EP) Mapping and Ablation Devices Market Share by Region, 2024 & 2033
6.5. North America
6.5.1. North America electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.5.2. U.S.
6.5.2.1. Key Country Dynamics
6.5.2.2. Regulatory Scenario
6.5.2.3. Competitive Scenario
6.5.2.4. U.S. electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.5.3. Canada
6.5.3.1. Key Country Dynamics
6.5.3.2. Regulatory Scenario
6.5.3.3. Competitive Scenario
6.5.3.4. Canada electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.5.4. Mexico
6.5.4.1. Key Country Dynamics
6.5.4.2. Regulatory Scenario
6.5.4.3. Competitive Scenario
6.5.4.4. Mexico electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.6. Europe
6.6.1. Europe electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.6.2. UK
6.6.2.1. Key Country Dynamics
6.6.2.2. Regulatory Scenario
6.6.2.3. Competitive Scenario
6.6.2.4. UK electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.6.3. Germany
6.6.3.1. Key Country Dynamics
6.6.3.2. Regulatory Scenario
6.6.3.3. Competitive Scenario
6.6.3.4. Germany electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.6.4. France
6.6.4.1. Key Country Dynamics
6.6.4.2. Regulatory Scenario
6.6.4.3. Competitive Scenario
6.6.4.4. France electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.6.5. Italy
6.6.5.1. Key Country Dynamics
6.6.5.2. Regulatory Scenario
6.6.5.3. Competitive Scenario
6.6.5.4. Italy electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.6.6. Spain
6.6.6.1. Key Country Dynamics
6.6.6.2. Regulatory Scenario
6.6.6.3. Competitive Scenario
6.6.6.4. Spain electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.6.7. Norway
6.6.7.1. Key Country Dynamics
6.6.7.2. Regulatory Scenario
6.6.7.3. Competitive Scenario
6.6.7.4. Norway electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.6.8. Sweden
6.6.8.1. Key Country Dynamics
6.6.8.2. Regulatory Scenario
6.6.8.3. Competitive Scenario
6.6.8.4. Sweden electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.6.9. Denmark
6.6.9.1. Key Country Dynamics
6.6.9.2. Regulatory Scenario
6.6.9.3. Competitive Scenario
6.6.9.4. Denmark electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.7. Asia Pacific
6.7.1. Japan
6.7.1.1. Key Country Dynamics
6.7.1.2. Regulatory Scenario
6.7.1.3. Competitive Scenario
6.7.1.4. Japan electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.7.2. China
6.7.2.1. Key Country Dynamics
6.7.2.2. Regulatory Scenario
6.7.2.3. Competitive Scenario
6.7.2.4. China electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.7.3. India
6.7.3.1. Key Country Dynamics
6.7.3.2. Regulatory Scenario
6.7.3.3. Competitive Scenario
6.7.3.4. India electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.7.4. Australia
6.7.4.1. Key Country Dynamics
6.7.4.2. Regulatory Scenario
6.7.4.3. Competitive Scenario
6.7.4.4. Australia electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.7.5. South Korea
6.7.5.1. Key Country Dynamics
6.7.5.2. Regulatory Scenario
6.7.5.3. Competitive Scenario
6.7.5.4. South Korea electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.7.6. Thailand
6.7.6.1. Key Country Dynamics
6.7.6.2. Regulatory Scenario
6.7.6.3. Competitive Scenario
6.7.6.4. Thailand electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.8. Latin America
6.8.1. Brazil
6.8.1.1. Key Country Dynamics
6.8.1.2. Regulatory Scenario
6.8.1.3. Competitive Scenario
6.8.1.4. Brazil electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.8.2. Argentina
6.8.2.1. Key Country Dynamics
6.8.2.2. Regulatory Scenario
6.8.2.3. Competitive Scenario
6.8.2.4. Argentina electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.9. MEA
6.9.1. South Africa
6.9.1.1. Key Country Dynamics
6.9.1.2. Regulatory Scenario
6.9.1.3. Competitive Scenario
6.9.1.4. South Africa electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.9.2. Saudi Arabia
6.9.2.1. Key Country Dynamics
6.9.2.2. Regulatory Scenario
6.9.2.3. Competitive Scenario
6.9.2.4. Saudi Arabia electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.9.3. UAE
6.9.3.1. Key Country Dynamics
6.9.3.2. Regulatory Scenario
6.9.3.3. Competitive Scenario
6.9.3.4. UAE electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.9.4. Kuwait
6.9.4.1. Key Country Dynamics
6.9.4.2. Regulatory Scenario
6.9.4.3. Competitive Scenario
6.9.4.4. Kuwait electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company Categorization
7.3. Company Profiles
7.3.1. Siemens Healthineers
7.3.1.1. Company overview
7.3.1.2. Financial performance
7.3.1.3. Product benchmarking
7.3.1.4. Strategic initiatives
7.3.2. Koninklijke Philips N.V.
7.3.2.1. Company overview
7.3.2.2. Financial performance
7.3.2.3. Product benchmarking
7.3.2.4. Strategic initiatives
7.3.3. Abbott
7.3.3.1. Company overview
7.3.3.2. Financial performance
7.3.3.3. Product benchmarking
7.3.3.4. Strategic initiatives
7.3.4. Johnson & Johnson (Biosense Webster)
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. GE HealthCare
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Boston Scientific Corporation
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Medtronic
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Biotronik SE & Co KG
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. MicroPort Scientific Corporation
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. CardioFocus, Inc.
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
°ü·ÃÀÚ·á